Steven Cohen

Last Update: 01-16-2018

Number of Stocks: 845
Number of New Stocks: 266

Total Value: $22,404 Mil
Q/Q Turnover: 38%

Countries: USA
Details: Top Buys | Top Sales | Top Holdings  Embed:

Steven Cohen' s Profile & Performance

Profile

Steven A. Cohen (also known as Stevie Cohen), a billionaire hedge fund investor, is the founder of SAC Capital Advisors, a Stamford, Connecticut based hedge fund which he continues to manage. Steven A. Cohen grew up in Great Neck, New York, and he attended the Wharton School of Business at the University of Pennsylvania. Steven A. Cohen lives in Greenwich, Connecticut with his wife and seven children.

Web Page:http://www.careers.sac.com/

Total Holding History

Performance of SAC Capital International Fund

YearReturn (%)S&P500 (%)Excess Gain (%)
20101515.06-0.1
200928.3926.461.9
2008-19-3718.0
3-Year Cumulative19.6 (6.1%/year)-8.3 (-2.9%/year)27.9 (9%/year)

Top Ranked Articles

Steven Cohen Dives Into Array BioPharma Guru keeps adding to positions in health care industry
On Sept. 11, Point72 manager Steven Cohen (Trades, Portfolio) invested in 6,766,507 shares of Array BioPharma Inc. (NASDAQ:ARRY), according to GuruFocus real-time picks. With this transaction, the guru increased his position 281.23%. Read more...
Steven Cohen Takes Stake in Karyopharm Therapeutics Guru increases position in health care space
Point72 Asset Management founder Steven Cohen (Trades, Portfolio) established a holding in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) on Nov. 3, further expanding his large positioning in the health care space. Read more...
Steven Cohen Picks Up Position in First Bancorp Guru invests in bank holding company
Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a stake in First Bancorp (NASDAQ:FBNC) on Dec. 12. Read more...
Steven Cohen Takes 5.7% Stake in Cancer Biopharma OncoSec Proprietary technology is in third stage to approval
Steven Cohen (Trades, Portfolio), chairman and CEO of hedge fund Point72 Asset Management, bought OncoSec Medical Inc. (NASDAQ:ONCS), stretching his sizable positioning in the healthcare industry. Read more...
Berkshire Hathaway Invests in STORE Capital Buffett takes 9.8% stake in REIT for $377 million
In its second big real estate bet in two weeks, Warren Buffett (Trades, Portfolio)’s Berkshire Hathaway Inc. (NYSE:BRK.A) (NYSE:BRK.B) took a 9.8% ownership stake in STORE Capital Corp. (NYSE:STOR) on June 26. Read more...
» More Steven Cohen Articles

Commentaries and Stories

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

5 Health Care Stocks in Gurus' Portfolios Amgen, Innoviva among stocks investors are buying Jim Simons, Steven Cohen, Joel Greenblatt - 5 Health Care Stocks In Gurus' Portfolios
According to the GuruFocus All-In-One Screener, the following health care stocks are popular among gurus. More...

  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Steven Cohen Picks Up Position in First Bancorp Guru invests in bank holding company Steven Cohen - Steven Cohen Picks Up Position In First Bancorp
Point72 Asset Management leader Steven Cohen (Trades, Portfolio) disclosed a stake in First Bancorp (NASDAQ:FBNC) on Dec. 12. More...

STEVEN COHEN, POINT72, BUY, FIRST BANCORP


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Sage Therapeutics Rises 70% on Strong Phase 2 Results Company announced positive top-line results from clinical trial Steven Cohen, Paul Tudor Jones, Ron Baron - Sage Therapeutics Rises 70% On Strong Phase 2 Results
Sage Therapeutics Inc.'s (NASDAQ:SAGE) share price increased 70% at market open Dec. 7 as the company announced strong top-line results from its Phase 2 clinical trial of SAGE-217, a treatment for moderate to severe major depressive disorder (MDD) in adults. More...

STEVEN COHEN, PAUL TUDOR JONES, RON BARON


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Steven Cohen Boosts Stake in Radius Health Company has burgeoning treatment for osteoporosis Steven Cohen - Steven Cohen Boosts Stake In Radius Health
Investor Steven Cohen (Trades, Portfolio) took notice of fast-growing biopharmaceutical company Radius Health (NASDAQ:RDUS), boosting his holdings by 405.6% on Nov. 24, GuruFocus RealTime Picks reported. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

9 Stocks Steven Cohen Keeps Buying The guru added to these positions in the past 2 quarters Steven Cohen - 9 Stocks Steven Cohen Keeps Buying
Point72 Asset Management was founded by Steven Cohen (Trades, Portfolio) in 2014 as the successor to SAC Capital. In both the second and third quarters, the guru invested in the following stocks: More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Zeke Ashton Peppers Portfolio With 3 New Positions Guru added 1 ETF and 2 stocks in the 3rd quarter Zeke Ashton, Steven Cohen - Zeke Ashton Peppers Portfolio With 3 New Positions
Zeke Ashton (Trades, Portfolio), managing partner of Centaur Capital Partners, invests in stocks based upon value principles. In the third quarter, Ashton established positions in Facebook Inc. (NASDAQ:FB), Cheesecake Factory Inc. (NASDAQ:CAKE) and the SPDR S&P 500 (SPY) exchange-traded fund. More...

ZEKE ASHTON, STEVEN COHEN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

The Curious Career of Steven Cohen Cohen has been spectacularly successful as an investor, but his image was tainted by an insider trading scandal. Additionally, his returns may not be as robust as the numbers suggest Steven Cohen, Warren Buffett - The Curious Career Of Steven Cohen
Few investment gurus have as controversial a record as Steven Cohen (Trades, Portfolio). He has won acclaim for outstanding returns over the long term, he’s been cursed for the way he does business by other Wall Streeters and he was at the center of an insider trading scandal, one that saw several of his traders convicted. More...

GURUS, STEVEN COHEN, SAC CAPITAL ADVISORS, POINT72, HEDGE FUND, SECURITIES AND EXCHANGE COMMISSION, INSIDER TRADING, MOSAIC THEORY OF INVESTING, FUNDAMENTALS, QUANTITATIVE, SHORT-TERM TRADING, SHORT S


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Steven Cohen Takes Stake in Karyopharm Therapeutics Guru increases position in health care space Steven Cohen - Steven Cohen Takes Stake In Karyopharm Therapeutics
Point72 Asset Management founder Steven Cohen (Trades, Portfolio) established a holding in Karyopharm Therapeutics Inc. (NASDAQ:KPTI) on Nov. 3, further expanding his large positioning in the health care space. More...

COHEN, BUY, POINT72, KARYOPHARM, PHARMA, HEALTH CARE


  • Currently 5.00/5

Rating: 5.0/5 (1 vote)

Steven Cohen Takes 5.7% Stake in Cancer Biopharma OncoSec Proprietary technology is in third stage to approval Steven Cohen - Steven Cohen Takes 5.7% Stake In Cancer Biopharma OncoSec
Steven Cohen (Trades, Portfolio), chairman and CEO of hedge fund Point72 Asset Management, bought OncoSec Medical Inc. (NASDAQ:ONCS), stretching his sizable positioning in the healthcare industry. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Twitter Soars on Earnings Beat, Potential Profit Next Quarter Social network readjusted MAUs due to miscalculation Jim Simons,Steven Cohen,Jeremy Grantham,Paul Tudor - Twitter Soars On Earnings Beat, Potential Profit Next Quarter
Social media platform Twitter Inc. (NYSE:TWTR) reported its third-quarter results before the opening bell on Oct. 26, rising on the chance of a potential fourth-quarter profit. More...

TWITTER, 3Q, EARNINGS, BEAT


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Andreas Halvorsen Dives into Deciphera Pharma Company launches initial public offering and reports recent study results Andreas Halvorsen, Steven Cohen, Warren Buffett - Andreas Halvorsen Dives Into Deciphera Pharma
Andreas Halvorsen (Trades, Portfolio), chief investment officer of Viking Global Investors, invested in 2,479,867 shares of Deciphera Pharmaceuticals Inc. (NASDAQ:DCPH) for $19.73 per share on Oct. 2, according to GuruFocus real-time picks. More...

ANDREAS HALVORSEN, STEVEN COHEN, WARREN BUFFETT


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

6 Stocks Growing Earnings and Revenue Signet Jewelers, Penske among companies increasing their profitability Steven Cohen, Jim Simons, Joel Greenblatt, Lee Ain - 6 Stocks Growing Earnings And Revenue
According to GuruFocus All-In-One Screener, the following companies have boosted their revenues and earnings over the last several years. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Steven Cohen Doubles Down on Sickle Cell Disease Therapeutics Company Global Blood Guru adds approximately 225% to the position Steven Cohen - Steven Cohen Doubles Down On Sickle Cell Disease Therapeutics Company Global Blood
On Oct. 2, Steven Cohen (Trades, Portfolio) increased his Global Blood Therapeutics Inc. (NASDAQ:GBT) position, according to GuruFocus real-time picks. More...

STEVEN COHEN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

6 Undervalued Stocks Growing Earnings Cracker Barrel, Molina Healthcare among companies increasing profitability Jim Simons, Steven Cohen, Joel Greenblatt,  Louis  - 6 Undervalued Stocks Growing Earnings
Companies growing their earnings per share (EPS) are often good investments as they can return a solid profit to investors. According to the discount cash flow (DCF) calculator, the following are undervalued companies that have grown EPS over a five-year period. More...

  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Northrop Grumman to Acquire Orbital ATK for $7.8 Billion The deal includes $1.4 billion in debt Jim Simons,Steven Cohen,Joel Greenblatt,George Sor - Northrop Grumman To Acquire Orbital ATK For $7.8 Billion
Global security company Northrop Grumman Corp. (NYSE:NOC) announced Sept. 18 it is buying missile maker Orbital ATK Inc. (NYSE:OA) for $7.8 billion in cash. More...

NORTHROP GRUMMAN, ORBITAL ATK, ACQUISITION, AEROSPACE, DEFENSE


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

7 Negative Assets in Gurus' Portfolios Gurus' holdings with falling prices and returns Jim Simons, Steven Cohen, Ronald Muhlenkamp, Joel  - 7 Negative Assets In Gurus' Portfolios
While gurus hold positions in these companies, the stock price and returns continue to fall. These are the worst-performing stocks over the last three months with a long-term presence in more than three gurus’ portfolios. More...

  • Currently 4.00/5

Rating: 4.0/5 (2 votes)

Steven Cohen Dives Into Array BioPharma Guru keeps adding to positions in health care industry Steven Cohen - Steven Cohen Dives Into Array BioPharma
On Sept. 11, Point72 manager Steven Cohen (Trades, Portfolio) invested in 6,766,507 shares of Array BioPharma Inc. (NASDAQ:ARRY), according to GuruFocus real-time picks. With this transaction, the guru increased his position 281.23%. More...

STEVEN COHEN


  • Currently 1.00/5

Rating: 1.0/5 (1 vote)

Bill Nygren Added Charter Communications in 2nd Quarter Fund manager also trimmed 3 other positions Bill Nygren, Steven Cohen, David Dreman - Bill Nygren Added Charter Communications In 2nd Quarter
Oakmark Fund manager Bill Nygren (Trades, Portfolio) invests in companies that trade at a significant discount to the expected intrinsic value. During the second quarter, Nygren invested in Charter Communications Inc. (NASDAQ:CHTR) and trimmed his positions in Anadarko Petroleum Corp. (NYSE:APC), Microsoft Corp. (NASDAQ:MSFT) and AutoNation Inc. (NYSE:AN). More...

BILL NYGREN, STEVEN COHEN, DAVID DREMAN


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

American Outdoor Brands Wounded by Quarterly Loss Gunmaker lowers guidance Chuck Royce,Steven Cohen,David Dreman,Joel Greenbl - American Outdoor Brands Wounded By Quarterly Loss
Firearms manufacturer American Outdoor Brands Corp. (NASDAQ:AOBC) reported its fiscal first-quarter 2018 results after the market closed on Sept. 7. More...

AMERICAN OUTDOOR BRANDS, SMITH & WESSON, EARNINGS, MISS, 2Q, LOSS


  • Currently 0.00/5

Rating: 0.0/5 (0 votes)

Duluth Holdings Up on Earnings Beat Retail company plans to open more stores this year Jim Simons,Steven Cohen,Chuck Akre - Duluth Holdings Up On Earnings Beat
Work apparel retailer Duluth Holdings Inc. (NASDAQ:DLTH) reported its performance for the second quarter after the market closed on Sept. 5. More...

DULUTH, EARNINGS, 2Q, BEAT, UP


Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}
FEEDBACK